iHuman Brianna Gill pain when I pee

10 June 2026

No Comments

iHuman assignment

iHuman Brianna Gill pain when I pee 28 year old answers

iHuman Brianna Gill pain when I pee 28 year old answers

Patient Demographic & Clinical Setting

  • Patient Name: Brianna Gill

  • Age & Gender: 28-Year-Old Female

  • Height & Weight: 5′ 2″ (157 cm) | 132.0 lbs (60.0 kg)

  • Chief Complaint (CC): “Pain when I pee”

  • Encounter Location: Outpatient Primary Care / Urgent Care Clinic (with laboratory, dipstick urinalysis, and X-ray capabilities)

iHuman Brianna Gill pain when I pee answers History Questions

  1. How can I help you today?
  2. Do you have any other symptoms or concerns we should discuss?
  3. Do you have pain/discomfort when you urinate?
  4. When did your pain/discomfort with urination start?
  5. What are the events surrounding the start of your pain/discomfort with urination?
  6. Does anything make your pain/discomfort with urination better or worse?
  7. How severe is your pain/discomfort with urination?
  8. Does your pain/discomfort with urination come and go?
  9. Have you passed any stones in your urine?
  10. How long does your urination pain/discomfort last?
  11. What treatments have you….

iHuman Brianna Gill pain when I pee answers NR602

Physical Exams

  1. Weight
  2. Height
  3. cognitive status
  4. SpO2
  5. temperature
  6. blood pressure
  7. pulse
  8. respiration
  9. temperature
  10. auscultate heart
  11. auscultate lungs
  12. assess …….
iHuman Kristina Hart pain when I pee answers

iHuman Brianna Gill: 28-Year-Old Female with Dysuria (Pain When I Pee) Case Study Answers

 

1. Focused Health History Questions

To achieve a high history score on this iHuman case, ask the following targeted questions to differentiate uncomplicated lower urinary tract infection (acute cystitis) from pyelonephritis, vaginitis, or sexually transmitted infections (STIs):

  1. How can I help you today?

    • Patient Response: “I have a burning pain whenever I pass urine.”

  2. When did your pain or discomfort with urination start?

    • Purpose: Establishes acute vs. chronic onset (typically 2–4 days duration).

  3. How severe is your pain on a scale of 1 to 10?

    • Purpose: Quantifies dysuria severity.

  4. Do you have to urinate more frequently than usual, or feel a sudden strong urge to go?

    • Purpose: Assesses classic lower urinary tract symptoms (frequency and urgency).

  5. Have you noticed any changes in the color or odor of your urine, or seen blood in your urine?

    • Purpose: Checks for hematuria, cloudiness, or malodorous urine indicative of acute bacterial cystitis.

  6. Do you have any flank pain, back pain, fever, chills, nausea, or vomiting?

    • Purpose: Critical red-flag screening to rule out acute pyelonephritis (upper UTI).

  7. Are you experiencing any abnormal vaginal discharge, vaginal itching, or pelvic pain?

    • Purpose: Distinguishes urethritis/cystitis from vulvovaginal candidiasis, bacterial vaginosis, or trichomoniasis.

  8. Are you currently sexually active, and do you use barrier protection or new personal hygiene products?

    • Purpose: Identifies behavioral risk factors and non-infectious irritants (e.g., contact dermatitis).

  9. Have you had similar urinary symptoms or urinary tract infections in the past?

    • Purpose: Evaluates for recurrent UTIs.

  10. Do you have any chronic medical conditions, such as diabetes mellitus or kidney stones?

    • Purpose: Rules out complicated UTI risk factors.

2. Essential Physical Examination Steps

Perform the following targeted physical exam maneuvers to confirm local clinical signs and rule out systemic involvement:

  • Vital Signs: Assess temperature (rule out fever), heart rate, blood pressure, respiratory rate, and SpO2.

  • General Appearance: Observe level of distress, comfort, and alertness.

  • Abdominal Examination:

    • Inspection of abdomen for distension.

    • Auscultation of bowel sounds across all four quadrants.

    • Palpation: Light and deep palpation for suprapubic tenderness (typical in acute cystitis) and guarding.

  • Costovertebral Angle (CVA) Tenderness: Perform direct percussion over the bilateral CVA (Kidney Punch Test) to evaluate for pyelonephritis (expected negative for uncomplicated cystitis).

  • Pelvic Examination (if indicated): Inspect for external lesions, cervical motion tenderness, or abnormal vaginal discharge to exclude PID/STI.

3. Diagnostic Reasoning & Differential Diagnoses

Primary Diagnosis

  • Acute Uncomplicated Cystitis (ICD-10: N30.00)

    • Clinical Rationale: Classic triad of acute dysuria, urinary frequency, and suprapubic discomfort in a young, non-pregnant female without systemic signs (fever, CVA tenderness, or flank pain). Most common causative organism is Escherichia coli.

Differential Diagnoses

  1. Acute Urethritis (STI-related: Chlamydia trachomatis / Neisseria gonorrhoeae)

    • Distinguishing Features: Gradual onset, internal dysuria, lack of suprapubic pain, potential mucopurulent vaginal discharge.

  2. Vulvovaginitis (Candidiasis / Bacterial Vaginosis)

    • Distinguishing Features: External dysuria (burning as urine hits irritated vulvar skin), vaginal itching, discharge, absence of urinary frequency.

  3. Acute Pyelonephritis (ICD-10: N10)

    • Distinguishing Features: Upper tract infection characterized by fever, rigors, flank pain, nausea, and positive CVA tenderness on examination.

4. Laboratory Findings & Diagnostic Workup

  • Dipstick Urinalysis (In-Office):

    • Leukocyte Esterase: Positive (indicative of pyuria).

    • Nitrites: Positive (indicative of Enterobacteriaceae such as E. coli).

    • Microscopic UA: >10 WBCs/HPF>10\text{ WBCs/HPF}, presence of bacteria, trace RBCs (microscopic hematuria).

  • Urine Culture & Susceptibility: Indicated if symptoms are atypical, recurrent, or if local resistance patterns dictate.

  • STI Nucleic Acid Amplification Test (NAAT): Urine or cervical swab for C. trachomatis and N. gonorrhoeae if sexually active with new/multiple partners.

5. Management & Treatment Plan

Pharmacotherapy (First-Line Empirical Therapy)

  • Nitrofurantoin Monohydrate/Macrocrystals (Macrobid): 100 mg100\text{ mg} PO BID for 5 days.

    • Alternative: Trimethoprim-Sulfamethoxazole (TMP-SMX DS): 160/800 mg160/800\text{ mg} PO BID for 3 days (if local resistance <20%<20\%).

    • Alternative: Fosfomycin Trometamol: 3 g3\text{ g} PO single dose.

  • Symptomatic Relief: Phenazopyridine (Pyridium): 200 mg200\text{ mg} PO TID PRN for 1–2 days for dysuria relief (advise patient on transient orange-red urine discoloration).

Patient Education & Counseling

  • Hydration: Maintain generous fluid intake (2–3 L2\text{–}3\text{ L} daily) to promote urinary flushing.

  • Hygiene Practices: Wipe front-to-back following bowel movements; void promptly after sexual intercourse.

  • Red-Flag Warnings: Instruct patient to seek immediate medical re-evaluation if fever, severe flank/back pain, nausea, vomiting, or persistent symptoms develop after completing antibiotics.